Fuller & Thaler Asset Management, Inc. Repligen Corp Transaction History

Fuller & Thaler Asset Management, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $10.8 Million - $13.8 Million	-69,850 Reduced 99.98%	13 $2,000
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $1.15 Million - $1.56 Million	7,052 Added 11.23%	69,863 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $55,826 - $89,161	348 Added 0.56%	62,811 $11.8 Million
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $203,986 - $272,629	1,450 Added 2.38%	62,463 $10.1 Million
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $161,995 - $259,249	1,005 Added 1.67%	61,013 $11.5 Million
Q4 2021 Feb 09, 2022	SELL	$247.59 - $304.47 $10,646 - $13,092	-43 Reduced 0.07%	60,008 $15.9 Million
Q3 2021 Nov 10, 2021	SELL	$194.77 - $324.21 $1.03 Million - $1.72 Million	-5,299 Reduced 8.11%	60,051 $17.4 Million
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $711,084 - $947,212	-4,287 Reduced 6.16%	65,350 $13 Million
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $208,688 - $261,782	1,157 Added 1.69%	69,637 $13.5 Million
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $185,248 - $258,419	1,251 Added 1.86%	68,480 $13.1 Million
Q3 2020 Nov 09, 2020	SELL	$122.51 - $158.27 $2.75 Million - $3.55 Million	-22,428 Reduced 25.02%	67,229 $9.92 Million
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $169,133 - $251,880	1,793 Added 2.04%	89,657 $11.1 Million
Q1 2020 May 06, 2020	SELL	$84.96 - $109.14 $173,403 - $222,754	-2,041 Reduced 2.27%	87,864 $8.48 Million
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $6.64 Million - $8.37 Million	89,905 New	89,905 $8.32 Million

479

54.9M

297K

343K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.